COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: finding
- PDF / 1,493,259 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 62 Downloads / 196 Views
RESEARCH ARTICLE
Open Access
COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry Samira Bell1,2* , Jacqueline Campbell2, Jackie McDonald2, Martin O’Neill2, Chrissie Watters2, Katharine Buck3, Zoe Cousland4, Mark Findlay5, Nazir I. Lone6, Wendy Metcalfe7, Shona Methven8, Robert Peel9, Alison Almond10, Vinod Sanu11, Elaine Spalding12, Peter C. Thomson5, Patrick B. Mark5, Jamie P. Traynor2,5 and on behalf of the Scottish Renal Registry
Abstract Background: Infection with the severe acute respiratory coronavirus 2 (SARS-CoV-2) has led to a worldwide pandemic with coronavirus disease 2019 (COVID-19), the disease caused by SARS-CoV-2, overwhelming healthcare systems globally. Preliminary reports suggest a high incidence of infection and mortality with SARS-CoV-2 in patients receiving kidney replacement therapy (KRT). The aims of this study are to report characteristics, rates and outcomes of all patients affected by infection with SARS-CoV-2 undergoing KRT in Scotland. Methods: Study design was an observational cohort study. Data were linked between the Scottish Renal Registry, Health Protection Scotland and the Scottish Intensive Care Society Audit Group national data sets using a unique patient identifier (Community Health Index (CHI)) for each individual by the Public Health and Intelligence unit of Public Health, Scotland. Descriptive statistics and survival analyses were performed. Results: During the period 1st March 2020 to 31st May 2020, 110 patients receiving KRT tested positive for SARS-CoV-2 amounting to 2% of the prevalent KRT population. Of those affected, 86 were receiving haemodialysis or peritoneal dialysis and 24 had a renal transplant. Patients who tested positive were older and more likely to reside in more deprived postcodes. Mortality was high at 26.7% in the dialysis patients and 29.2% in the transplant patients. (Continued on next page)
* Correspondence: [email protected] 1 Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee DD1 9SY, UK 2 The Scottish Renal Registry, Scottish Health Audits, Public Health & Intelligence, Information Services, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE, UK Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regula
Data Loading...
